The first three babies screened at the embryonic stage with karyomapping, a novel screening tool for genetic disease, have been born…
For couples who are at risk of passing on genetic disease to their offspring, the technology helps determine which embryos are disease-free and viable for implantation following in vitro fertilization (IVF), according to the firm, New Jersey-based Reprogenetics.
Although preimplantation genetic diagnosis (PGD) has been available for decades, karyomapping takes advantage of advances in genetic sequencing that have reduced the price, time, and complexity of the process. Thus, the main benefit of karyomapping is the diminished amount of time it takes for couples to get results and get pregnant, company officials said…
“This is considered the ‘inevitable evolution’ of genetic studies for our field,” Robert Greene, MD, a reproductive endocrinologist in Syracuse, N.Y., told MedPage Today. “The race … has been in making the technique practical. It will only be adopted clinically if it meets those practical considerations. Otherwise, most centers will stick with the current technique until the price comes down…”
As with other forms of PGD, karyomapping can test for genetic diseases such as Down syndrome, cystic fibrosis, and fragile X syndrome. Konstantinidis said the tool can detect 60 genetic disorders and has been performed on more than 1,000 embryos to date.
Another simple scientific tool enabling easier, broader choices to folks getting ready to have children. Hopefully, a decision involving some forethought.
Hopefully, a process liable to lass and less interference from politicians governed by pandering to superstition and ignorance.